Live Webinar on A Risk-Based Approach to Monitoring: May 14



Topic: New FDA Draft Guidance – A Risk-Based Approach to Monitoring of Clinical Investigations

Date: May 14, 2019

Time: 1:00 p.m. – 2:00 p.m. EDT

Duration: 60 minutes

Sponsored by: Life Science Training Institute

Webinar: Live interactive session. Recording will be available for 30 days.

Sign up here.


The FDA released a draft Question and Answer guidance supporting and clarifying the finalized guidance on risk-based monitoring. Major areas it covers are how to plan your monitoring approach, developing your monitoring plan, and communication of results.

Join our own Sandra “SAM” Sather for this interactive training session on a risk-based approach to monitoring. Learn how the FDA draft guidance affects you.

Key take away benefits:

  • Understand what elements should be included in your monitoring plan for a risk-based monitoring approach

  • Learn how to apply risk management to developing a monitoring plan responsive to site performance

  • Recognize key activities for an effective site communication plan

To view our inventory of interactive eLearning courses, click here.


- The Clinical Pathways Team

Enjoy this blog? Please like, comment, and share with your contacts.